|
Name |
Carotol
|
| Molecular Formula | C15H26O | |
| IUPAC Name* |
(3R,3aS,8aR)-6,8a-dimethyl-3-propan-2-yl-1,2,3,4,5,8-hexahydroazulen-3a-ol
|
|
| SMILES |
CC1=CC[C@]2(CC[C@@H]([C@]2(CC1)O)C(C)C)C
|
|
| InChI |
InChI=1S/C15H26O/c1-11(2)13-7-9-14(4)8-5-12(3)6-10-15(13,14)16/h5,11,13,16H,6-10H2,1-4H3/t13-,14+,15+/m1/s1
|
|
| InChIKey |
XZYQCFABZDVOPN-ILXRZTDVSA-N
|
|
| Synonyms |
Carotol; 465-28-1; (+)-Carotol; (+)-8-Daucen-5-ol; NT5C9M36DE; Carotol, (+)-; UNII-NT5C9M36DE; CAROTOL [MI]; CHEBI:3431; SCHEMBL6514107; DTXSID101318114; ZINC1729384; LMPR0103550001; (3R,3aS,8aR)-6,8a-dimethyl-3-propan-2-yl-1,2,3,4,5,8-hexahydroazulen-3a-ol; 3aalpha(1H)-Azulenol, 2,3,4,5,8,8a-hexahydro-3alpha-isopropyl-6,8aalpha-dimethyl-, (+)-; C09628; Q5045553; (3R,3AS,8AR)-2,3,4,5,8,8A-HEXAHYDRO-6,8A-DIMETHYL-3-(1-METHYLETHYL)-3A(1H)-AZULENOL; 3A(1H)-AZULENOL, 2,3,4,5,8,8A-HEXAHYDRO-6,8A-DIMETHYL-3-(1-METHYLETHYL)-, (3R,3AS,8AR)-; 3a(1H)-Azulenol, 2,3,4,5,8,8a-hexahydro-6,8a-dimethyl-3-(1-methylethyl)-, (3R-(3alpha,3aalpha,8aalpha))-
|
|
| CAS | 465-28-1 | |
| PubChem CID | 442347 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 222.37 | ALogp: | 3.6 |
| HBD: | 1 | HBA: | 1 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 20.2 | Aromatic Rings: | 2 |
| Heavy Atoms: | 16 | QED Weighted: | 0.644 |
| Caco-2 Permeability: | -4.399 | MDCK Permeability: | 0.00002230 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.642 |
| 30% Bioavailability (F30%): | 0.568 |
| Blood-Brain-Barrier Penetration (BBB): | 0.098 | Plasma Protein Binding (PPB): | 96.67% |
| Volume Distribution (VD): | 1.617 | Fu: | 3.09% |
| CYP1A2-inhibitor: | 0.514 | CYP1A2-substrate: | 0.39 |
| CYP2C19-inhibitor: | 0.399 | CYP2C19-substrate: | 0.9 |
| CYP2C9-inhibitor: | 0.375 | CYP2C9-substrate: | 0.398 |
| CYP2D6-inhibitor: | 0.041 | CYP2D6-substrate: | 0.2 |
| CYP3A4-inhibitor: | 0.263 | CYP3A4-substrate: | 0.513 |
| Clearance (CL): | 11.771 | Half-life (T1/2): | 0.168 |
| hERG Blockers: | 0.04 | Human Hepatotoxicity (H-HT): | 0.1 |
| Drug-inuced Liver Injury (DILI): | 0.041 | AMES Toxicity: | 0.006 |
| Rat Oral Acute Toxicity: | 0.028 | Maximum Recommended Daily Dose: | 0.026 |
| Skin Sensitization: | 0.626 | Carcinogencity: | 0.327 |
| Eye Corrosion: | 0.719 | Eye Irritation: | 0.938 |
| Respiratory Toxicity: | 0.076 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000388 | ![]() |
0.469 | D01CKY | ![]() |
0.258 | ||
| ENC001637 | ![]() |
0.469 | D07QKN | ![]() |
0.250 | ||
| ENC003268 | ![]() |
0.443 | D04GJN | ![]() |
0.247 | ||
| ENC005115 | ![]() |
0.406 | D0SC8F | ![]() |
0.241 | ||
| ENC001824 | ![]() |
0.400 | D0Z1XD | ![]() |
0.238 | ||
| ENC001135 | ![]() |
0.400 | D0Y7LD | ![]() |
0.235 | ||
| ENC003502 | ![]() |
0.392 | D0I2SD | ![]() |
0.233 | ||
| ENC002017 | ![]() |
0.387 | D04ATM | ![]() |
0.231 | ||
| ENC000588 | ![]() |
0.377 | D0K0EK | ![]() |
0.229 | ||
| ENC001813 | ![]() |
0.377 | D0L2LS | ![]() |
0.227 | ||